Clinical Trial Update: Efficacy and Safety Of Xeloda as Sequential Adjuvant Therapy After Chemotherapy in Breast Cancer [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update examines the efficacy and safety of Xeloda (capecitabine) as sequential adjuvant therapy after chemotherapy in breast cancer, coverin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Xeloda (capecitabine)

Snippet

Sponsor: Tianjin Medical University | Conditions: Breast Cancer | Phase 2, Phase 3 | Status: UNKNOWN